MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2018 International Congress

    Who uses guidance techniques for abobotulinumtoxinA injections in the routine management of cervical dystonia?

    V. Misra, R. Trosch, P. Maisonobe, S. Om (London, United Kingdom)

    Objective: Describe the use of injection guidance techniques in different cervical dystonia (CD) patient populations treated in routine practice. Background: The use of injection guidance…
  • 2018 International Congress

    Duration of response with abobotulinumtoxinA in cervical dystonia: Patient distribution results from two open label extension studies

    R. Hauser, D. Truong, M. Jog, D. Grimes, P. Picaut, A. Mann (Tampa, FL, USA)

    Objective: To report patient distribution data for duration of response with abobotulinumtoxinA (aboBoNT-A; Dysport®) from two open-label (OL) studies in patients with cervical dystonia (CD).…
  • 2018 International Congress

    A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

    W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)

    Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…
  • 2018 International Congress

    Response to botulinum toxin in adult onset lower limb dystonia

    D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)

    Objective: To describe the response to treatment with botulinum toxin in a cohort with adult onset lower limb dystonia. Background: Adult onset, lower limb dystonia…
  • 2018 International Congress

    Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia

    C. Comella, A. Brashear, J. Jankovic, D. Truong, A. Patel, M. Evatt, N. Kapa, Y. Liu, T. Nguyen-Cleary (Chicago, IL, USA)

    Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…
  • 2018 International Congress

    Botulinum toxin A injection for treatment of adductor spasmodic dysphonia under guidance of fiber laryngoscope combined with needle electromyography: 2 case reports

    X. Zhang, Z. Zhang, Y. Pan, L. Jin (Shanghai, China)

    Objective: To report two cases of adductor spasmodic dysphonia that treated with botulinum toxin A under fiber laryngoscope combined with needle electromyography guidance. Background: Spasmodic…
  • 2018 International Congress

    Using tablet devices to educate patients about dystonia and botulinum toxin for movement disorders

    S. Bobker, A. Hanineva, P. Popa, H. Ellsworth, X. Wu, I. Diaz, N. Hellmers, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To assess the efficacy of tablet-based learning modules for patient education in an outpatient movement disorders center. Background: Educational materials improve patient understanding, and…
  • 2018 International Congress

    Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
  • 2018 International Congress

    5 Years’ Experience of Ixcellence Network®, an International Innovative Educational Program to improve Cervical Dystonia and Spastic paresis Management Practices

    C. Colosimo, T.M. Chung, L.J. Jacinto, K. Bahtia, T. Landreau, R. Bhidayasiri (Roma, Italy)

    Objective: To describe the impact of the Ixcellence® Network training program on physicians using botulinum neurotoxin-A (BoNT-A) in cervical dystonia (CD) and spastic paresis (SP).…
  • 2018 International Congress

    Combined EMG and endoscopy guided botulinum toxin injection of the longus capitis muscle in cervical dystonia with anterocaput

    J. Michelis, F. Schuler, I. Debove, J. Müllner, L. Lachenmayer, E. Seifert (Bern, Switzerland)

    Objective: To describe a safe and well tolerated technique of botulinum toxin (BnTA) injection into the longus capitis muscle (LCM) in a patient with anterocaput…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley